Key points are not available for this paper at this time.
expression and CD8 immune populations as predictive biomarkers of pembrolizumab response in Sézary syndrome.
Su et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: